Technical Analysis for VALN - Valneva SE
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 7.72 | 0.18% | 0.01 |
VALN closed up 0.18 percent on Monday, March 18, 2024, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: Mar 21
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Weak + Overbought | Other | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Stochastic Reached Overbought | Strength | 0.18% | |
Weak + Overbought | Other | 0.18% | |
Inside Day | Range Contraction | 0.18% | |
Overbought Stochastic | Strength | 0.18% | |
Bearish Engulfing | Bearish | 4.02% | |
Outside Day | Range Expansion | 4.02% | |
Gapped Up | Strength | 4.02% | |
Calm After Storm | Range Contraction | 3.39% |
Alert | Time |
---|---|
Possible NR7 | about 11 hours ago |
60 Minute Opening Range Breakdown | about 13 hours ago |
Down 1% | about 13 hours ago |
Rose Above Previous Day's High | about 14 hours ago |
60 Minute Opening Range Breakout | about 15 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/21/2024
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Infectious Diseases Vaccines Medical Research Vaccination Virology Lyme Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Infectious Diseases Vaccines Medical Research Vaccination Virology Lyme Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 17.05 |
52 Week Low | 6.5901 |
Average Volume | 10,692 |
200-Day Moving Average | 11.71 |
50-Day Moving Average | 8.11 |
20-Day Moving Average | 7.19 |
10-Day Moving Average | 7.24 |
Average True Range | 0.36 |
RSI (14) | 53.70 |
ADX | 17.58 |
+DI | 24.13 |
-DI | 14.68 |
Chandelier Exit (Long, 3 ATRs) | 7.30 |
Chandelier Exit (Short, 3 ATRs) | 7.67 |
Upper Bollinger Bands | 7.77 |
Lower Bollinger Band | 6.61 |
Percent B (%b) | 0.96 |
BandWidth | 16.19 |
MACD Line | -0.16 |
MACD Signal Line | -0.32 |
MACD Histogram | 0.155 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 8.08 | ||||
Resistance 3 (R3) | 8.05 | 7.90 | 8.02 | ||
Resistance 2 (R2) | 7.90 | 7.81 | 7.92 | 8.00 | |
Resistance 1 (R1) | 7.81 | 7.75 | 7.86 | 7.84 | 7.98 |
Pivot Point | 7.66 | 7.66 | 7.68 | 7.68 | 7.66 |
Support 1 (S1) | 7.57 | 7.57 | 7.62 | 7.60 | 7.46 |
Support 2 (S2) | 7.42 | 7.51 | 7.44 | 7.44 | |
Support 3 (S3) | 7.33 | 7.42 | 7.42 | ||
Support 4 (S4) | 7.36 |